Financials
- Market Capitalization 199.61 M
- Employee 108
- Founded 2015
- CEO N/A
- Website www.nkartatx.com
- Headquarter Delaware, United States
- FIGI BBG00JXHS9G7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.31
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3613 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 73.91 USD | -0.05% | +0.03% | +1.25% | +833.21% | 205.92 M USD | ||
| 3616 | CDXS Codexis, Inc. - Common Stock | 2.25 USD | -7.41% | -14.45% | -9.27% | -27.18% | 204.52 M USD | ||
| 3630 | IMUX Immunic, Inc. - Common Stock | 14.64 USD | -0.88% | -1.61% | +4.87% | +1622.35% | 199.42 M USD | ||
| 3631 | NERV Minerva Neurosciences, Inc - Common Stock | 4.27 USD | -9.53% | -13.21% | -7.38% | +142.61% | 198.93 M USD |